Trial Profile
Bioavailability and Pharmacodynamic study (phase1) of Disgren EC capsule(Triflusal 300mg)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Triflusal (Primary)
- Indications Myocardial infarction; Thromboembolism; Unstable angina pectoris
- Focus Pharmacokinetics
- Sponsors Myung In
- 06 Sep 2016 New trial record